Antibiotic-resistant bacteria are a major global health threat that continues to rise due to a lack of effective vaccines. Of concern are Klebsiella pneumoniae that fail to induce in vivo germinal center B cell responses, which facilitate antibody production to fight infection. Immunotherapies using antibodies targeting antibiotic-resistant bacteria are emerging as promising alternatives, however, cannot be efficiently derived ex vivo, necessitating the need for immune technologies to develop therapeutics. Here, four-arm PEG-organoids were developed to elucidate the effects of polymer endpoint chemistry, integrin ligands, and mode of K. pneumoniae antigen presentation on germinal center- 3
Introduction
Bacterial infections remain a major global health problem, causing more than 5 million deaths annually 1 . Antibiotics are currently the standard medical intervention for several bacterial pathogens, including K. pneumoniae 4, 5 , but often fail to mediate broad protection against different serotypes.
Developing antibodies with high cross-reactivity requires enhanced understanding of the underlying immune response, which typically involves a germinal center B cell response in lymph nodes that makes high-affinity antibodies through iterative somatic hyper mutation and affinity maturation processes 6, 7 . Unfortunately, the polysaccharide antigens on many gram-negative bacteria fail to induce robust germinal center responses in vivo, which necessitates the development of an ex vivo immune technology, where the germinal center reaction can be induced irrespective of antigen type and form.
However, the development of such immune technologies is non-trivial as factors that spatially and temporally regulate the ex vivo germinal center response, ranging from microenvironment to antigen format, are poorly understood. The goal of the current study is to identify these factors and engineer a materials-based immune technology.
During an immune response to bacterial and viral infections, naïve B cells in the lymph node and spleen, encounter antigen and form sub-anatomical structures within B cell follicles in secondary lymphoid organs, referred to as germinal centers. Antigen-activated germinal center B cells undergo rapid proliferation and somatic hypermutation of their immunoglobulin variable genes. The proliferating B cells mutate their B cell receptors to produce mutant germinal center B cell clones with a range of affinities against the activating antigen 8, 9 , which regulates cross-reactivity against serotypes. The germinal center response is a complex process involving multiple cell types and environmental cues [10] [11] [12] . B cell follicles are composed of B cells, CD40 ligand (CD40L) presenting follicular T helper (T FH ) cells, B cell activating follicular dendritic cells (FDCs) [13] [14] [15] , extracellular matrix (ECM) proteins such as Arg-Gly-Asp (RGD)-presenting vitronectin 16, 17 , and several other factors. For example, integrin-mediated interactions between B cells and FDCs influence germinal center B cells 12 . B cell activation is marked by epigenetic regulation and immune receptor signaling, which come into play at critical transitional stages of the germinal center reaction 18, 19 . In the germinal center reaction, there is transient suppression of enhancers and promoters of genes that regulate immune signaling pathways, antigen presentation, and checkpoints, which revert to the active state when germinal center B cells are signaled to exit the germinal center reaction. Exit from the germinal center reaction occurs by differentiating into antibody-producing plasma cells or memory B cells.
Currently, the tissue and microenvironment factors governing B cell dynamics, temporal expression of phenotypic and epigenetic markers, and exit from the germinal center reaction are not well understood.
Early efforts to elucidate B cell differentiation involved a controlled environment of naïve B cells cocultured in 2D with stromal cells, called 40LB. These cells were engineered to provide critical signals for B cell survival and differentiation, including the T cell signal CD40L and B cell activating factor (BAFF), secreted in vivo by FDCs. However, the in vitro 2D presentation of these signals is not sufficient for induction of a germinal center response that resembles an in vivo-like response 19 , suggesting a critical role for the 3D microenvironment. Indeed, we have previously shown that incorporation of naïve B cells and 40LB in 3D organoids engineered from gelatin and silicate nanoparticles can significantly drive germinal center B cell phenotype, transcriptome, and somatic hypermutation just after 4 days ex vivo 19 , similar to in vivo immunized mice. To better decouple the signals driving this response, we further engineered modular organoids with tunable microenvironments using a four-arm polyethylene glycol presenting maleimide (PEG-4MAL) functionalized with thiolated ECM-mimicking peptides and enzymatically degradable crosslinkers 20 .
Using this system, we have shown that interactions between integrins and VCAM-1-mimicking peptide regulated phosphorylation of key proteins in the B cell receptor (BCR) signaling 20 . However, to date, the role of PEG end-group chemistry in regulating the germinal center response and contributions of microenvironment-epigenome interactions have not yet been explored, despite that such interactions would be expected to regulate cell behavior.
In the current work, our goal was to identify factors, including polymer end-point chemistry, integrin thereafter performing sequencing and analysis on > 14,000 single cells.
We analyzed this single-cell RNA sequencing dataset of lymph node stromal cells, including cells located in the B cell follicle, to determine various genes that bind to integrins. We observed that a compared to naïve B cells ( Figure 1D ). This observation supports the need for developing immune organoids that can be remodeled by MMP-9 secreted by activated B cells, as demonstrated in the next section.
The end group functionality in PEG hydrogels impacts B cell survival and induction of germinal center response
To study the effect of various extracellular matrices and integrin binding proteins found in the B cell follicle, we chose to use Poly(ethylene glycol) (PEG) hydrogels based on 4-arm PEG macromers with either terminal vinyl sulfone (PEG-4VS), acrylate (PEG-4Acr), or maleimide groups (PEG-4MAL) (Figure 2A ). These polymers can be functionalized to present integrin-specific peptides that are cysteine-terminated via a Michael-type addition reaction and crosslinked using di-thiolated crosslinkers at physiological pH and temperature under mild conditions 21 , as opposed to UV crosslinking ( Figure 2B ). While all three chemical functionalities in PEG hydrogels have been studied for a wide range of mammalian cells, they have never been compared directly to each other for their impact on primary B cells for the induction of germinal centers. This is an important biomaterial consideration given the growing interest in building immune tissues [22] [23] [24] and inability of natural matrices in supporting the diverse set of immune cells ex vivo.
We first characterized the survival of our engineered stromal cell 40LB Figure 1D ). We observed high viability among fast gelling PEG-4MAL hydrogels irrespective of the crosslinker pH and VPM:DTT ratio (50 or 100% VPM) ( Figure 2C ). In contrast, PEG-4VS at 50% VPM or PEG-4MAL at either 50% or 100% VPM, both of which gelled slowly at lower PEG macromer (pH 6), showed cytotoxic effects on 40LB stromal cells ( Figure 2C ).
There were no major differences between the stability of hydrogels ( Figure 2D ), except that slow degrading hydrogels formed a more uniform hydrogel than fast gelling ones, which can be attributed to wrinkling due to rapid pipetting of fast gelling hydrogels. We, therefore, continued with formulations that showed high viability so that the effects can be delineated between B cells and 40LBs.
We next examined the effect of polymer chemistry on B cell viability and induction of germinal center . 20 , and therefore RDG only groups were not included in the current study. We did, however, incorporate RDG scramble peptides in the organoids as a filler to overcome solubility and viscosity issues when 100%
GFOGER is used. Therefore, we used 0. CD19+GL7+Fas+ phenotype by ~ 10% as compared to REDV and RGD peptides ( Figure 3C ). There were no significant differences between REDV and RGD peptides in the induction of CD19+GL7+Fas+ population. Similarly, we observed a significant increase in the number of CD19+GL7+Fas+ cells in GFOGER-organoids than in other matrices ( Figure 3D ). By day 6, the differences between matrices were lost, suggesting that matrices can play a role in the initial time Because 40LBs are fibroblasts, it is unclear whether GFOGER binds directly to B cells in organoids or functions via 40LB cells, or whether the effect is mediated by high expression of β 1 and its interaction with the triple helical GFOGER peptide as compared to the linear REDV and RGD peptides.
Therefore, further investigation is needed to determine the mode of functioning of GFOGER in organoids. Along these lines, we had previously reported a gelatin-silicate nanoparticle-based immune organoid that presented RGD motifs to B cells 19, 42 . In these studies, the immune organoids showed remarkable similarity to in vivo germinal center B cells transcriptome, somatic hypermutation, EZH2 and We observed no significant difference in B220+EZH2+ B cells on day 4 across the matrices, however the EZH2+ cells decreased in a matrix dependent manner by day 6 ( Figure 4B ). Although the decrease in all three matrices was significant compared to day 4, REDV only reduced the cells by 14%
GFOGER and REDV regulate germinal center B cell epigenetic hallmarks EZH2 and

H3k27Me3 in a CD40L-and BCL6-dependent manner
and RGD by 24%, as compared to 30% reduction in EZH2 in GFOGER-organoids ( Figure 4C ).
Notably, ~60-65% of the B220+ B cells were positive for EZH2 hi on day 4. Percent and number of B220+EZH2hi cells followed a similar trend with matrices and temporal response, and the number of cells did not change for REDV and RGD over 6 days but only for GFOGER-functionalized organoids ( Figure 4D, E) . Similarly, the number of B220+EZH2+H3k27Me3+ cells did not change for REDV and RGD but only for GFOGER-functionalized organoids. Nearly all EZH2hi+ cells were also positive for H3k27Me3 ( Figure 4F ). We next evaluated the expression of H3k27Me3, as it represents the methyltransferase activity of EZH2. On day 4, VCAM-1 mimicking REDV-organoids expressed the highest levels of H3k27Me3 ( Figure 4G ). In contrast, differences between ECMs were insignificant on day 6. The drop in H3k27Me3 expression by day 6 was significant across all matrices with ~53% drop in REDV compared to a significantly lower 32% drop in GFOGER and RGDorganoids ( Figure 4H ).
Finally, we sought to determine whether the change in H3k27Me3 expression was regulated by the presence of T cell signal CD40L and BCL6. To understand this, we inhibited the CD40-CD40L
interaction by initiating the germinal center response and then inhibiting on day 1 or day 2. Likewise, we inhibited BCL6 expression on day 1 or day 2 of culture. After inhibition, on day 4, we observed a significant decrease in the expression of H3k27Me3 ( Figure 4I ), clearly indicating that the H3k27Me3 was regulated by the induction of the germinal center response in organoids.
Effect of bacterial antigen recognition on germinal center B cell differentiation in young mice
The rise of antibiotic resistance among clinically relevant bacteria is one of the most prominent public health challenges of the modern era. Klebsiella pneumonia, in particular, is one of the most frequent As a classic T cell-independent antigen, K. pneumoniae's glycan antigens fail to induce strong germinal center reactions to generate and select high-affinity antibody variants by affinity maturation.
In contrast, T cell-dependent responses are typically directed against protein antigens and although K. Figure 5E ) and the differences in EZH2 expression became indistinguishable ( Figure 5F ). More importantly, the expression of H3k27Me3 by day 8 increased in organoids exposed to sOmpA. These findings suggest that, at least ex vivo, histone methylation is more robust with sOmpA than membrane embedded antigen, highlighting the potential for future purified protein antigens without added LPS components.
Organoids predict the efficacy of bacterial antigen recognition on germinal center B cell differentiation in aged mice
We next sought to investigate the efficacy of KlebOM and sOmpA on germinal center B cell differentiation in aged mice and determine whether antigen mediated immune response can be generated in B cells from aged individuals, who are at increased risk of K. pneumoniae infections 44 .
Aging mice display many similar features of human immune aging -including reduced humoral immune responses to vaccination, which has been attributed to a defective T FH cell function in germinal centers 45 and immunosenescence of B cells including reduced expression of genes crucial to differentiation and somatic hypermutation 46 . However, the precise immunological mechanisms remain unclear and therefore a more reliable, higher throughput approach to generate antibodies is using organoids. We tested the ability of organoids to Nevertheless, the expression of H3k27Me3 in B220+EZH2+H3k27Me3+ B cells were higher in conditions with sOmpA ( Figure 6G ) and correlated with a concomitant increase in BCL6 ( Figure 6H ).
Therefore, it is evident that by using organoids, we can generate germinal center-like B cells in aged mice, that are initially low in numbers but follow a trajectory similar to young B cells in predicting the response of sOmpA versus KlebOM.
Conclusion
This work brings together several innovative concepts together, ranging from the effect of polymer 
Materials and Methods
Biomaterials and peptides
Four-arm polyethylene glycol-maleimide (PEG-MAL) with 20 kDa molecular weight and ≥ 90% purity was purchased from Laysan Bio. Integrin α vβ3-binding RGD peptide (GRGDSPC, >90% purity), scrambled peptide (GRDGSPC, >90% purity), integrin α 4β1-binding REDV peptide (GREDVGC, >90% purity), GFOGER peptide (GYGGGPGPPGPPGPPGPPGPPGFOGERGPPGPPGPP GPPGPPGPC, ≥ 90% purity), and matrix metalloproteinase (MMP)-9 degradable VPM peptide (GCRDVPMSMRGGDRCG, >90% purity) were purchased from Aapptec. Non-degradable dithiothreitol (DTT) crosslinker was purchased from Sigma Aldrich. All components were reconstituted in 0.01 M HEPES buffer with pH 7.4.
Stromal cell culture and mitomycin-c treatment
40LB stromal cells, genetically modified from NIH/3T3 fibroblasts to express CD40 ligand and produce B cell activating factor, as described previously 19, 20, [25] [26] [27] 47 , were obtained from Dr. Daisuke Kitamura 27 . 40LB cells were cultured in Dulbecco's Modified Eagle Medium containing 10% fetal bovine serum and 1% penicillin streptomycin, and routinely passaged at 90% confluency. Prior to encapsulation in organoids, 40LB were mitotically inhibited via incubation with 0.01 mg/mL mitomycin-C at 37°C for 45 min.
Naïve B cell isolation from mice
For experiments involving wildtype (WT) B cells, spleens were harvested from female C57BL/6 mice, aged 8-15 weeks, from the Jackson Laboratory. Where indicated, mice aged >2 years were used to compare the effects of aging. Spleens were dissociated using a sterile plunger, as previously described 26 , and the cell suspension was incubated in RBC lysis buffer for 5 min at room temperature to remove red blood cells. Naïve B cells were purified from the splenocyte suspension by negative isolation using an EasySep Mouse B Cell Isolation Kit from Stem Cell Technologies, according to the manufacturer's instructions. All animals were handled in compliance with the procedures approved by the Institutional Animal Care and Use Committee (IACUC) at Cornell University.
Organoid fabrication
Synthetic immune organoids containing 7.5% PEG-4MAL or 7.5% PEG-4VS or 7.5% PEG-4Acr
were fabricated using a 4-arm PEG-MAL macromer, adhesives peptides and crosslinkers. PEG- 
Inhibition of CD40L and BCL6
Where indicated, organoid media was replenished on days 1 or 2 with 50 μg/mL mouse anti-CD40L
(Clone MR-1, Bio X Cell #BE0017-1), 50 μM BCL6 inhibitor 79-6 (Sigma #197345), or 10 ng/mL IL-4 alone. Changes in germinal center-like B cell dynamics were assessed on day 4 of organoid culture using flow cytometry.
Enrichment of K. pneumoniae outer membranes (KlebOM)
Outer membranes were enriched from a clinical Klebsiella pneumoniae stool isolate, designated at B308-2, provided and profiled for antibiotic resistance by Michael Satlin at Weill Cornell Medicine.
This isolate is here referred to as KpB308-2. KpB308-2 was inoculated in 500mL Nutrient Broth with 100ug/mL ampicillin and incubated overnight at 37°C, shaking 220 rpm. Following incubation, cells were pelleted at 5,000xg for 40 minutes at 4°C and resuspended in 36 mL lysis buffer (20mM Tris Buffer pH 8.0, 750mM Sucrose,) with 10 mg/mL egg white lysozyme and incubated on ice shaking 180 rpm for 1 hour. Ice cold 1.5mM EDTA was slowly poured into the lysozyme-treated cells and 1x
protease inhibitor was added (Roche cat no. 04693159001). The suspensions were sonicated in an ice/water slurry for eight minutes total with the following parameters: 20 seconds on/20 seconds off, 70% amplitude. 1mM PMSF was added to the lysates, which were then spun at 1,500xg for 15 minutes at 4°C to remove large debris and unlysed cells. The supernatant was collected and spun at 100,000xg for 1 hour, 4°C to pellet membranes. The supernatant containing the soluble cytosolic fraction was removed and saved for analysis, and the pelleted membranes were resuspended in 2mL membrane wash buffer (20mM Tris Buffer pH 8.0, 300mM NaCl, 1x protease inhibitor, 1mM fresh PMSF) passaged through and 18g needle, washed in an additional 10mL supplemented wash buffer, and spun again at 100,00xg, 1 hour, 4°C. Total membrane pellets were resuspended via a 18g needle in 1% N-Lauroylsarcosine (Sigma #L5125) in supplemented wash buffer and incubated rolling at room temperature for 1 hour to selectively solubilize inner membranes 48 . The remaining insoluble outer membrane fraction was pelleted at 100,000xg for 1 hour, 4°C. The supernatant containing solubilized inner membranes was removed and saved for analysis; and the enriched outer membrane pellet was resuspended once more in 10 mL supplemented membrane wash buffer, and pelleted a final time at 100,000xg, 4°C, for 1 hour. Finally, the enriched outer membrane pellet was resuspended in 3 mL of 20mM Tris-HCl, pH 8.0, 150mM NaCl, passed through a 0.22uM filter, and flash frozen until further use. Total protein concentration was measured using a Qubit 2. Approximately 3.2 μg KlebOM were supplemented to the media for each organoid.
Western Blotting
To identify enrichment of KpB308-2 outer membranes, western blot was against the outer membrane marker Outer Membrane Protein A (OmpA). 15ug of total protein was mixed with 1X NuPage LDS sample buffer (NP0007) and 2.5% beta-mercaptoethanol, heated at 95°C for 5 minutes, then loaded into a 4-12% NuPage Bis-Tris gel. Protein was transferred to a nitrocellulose membrane using an iBlot 2 and blocked in 5% Skim milk powder in TBST for 1 hour at room temperature. The membrane was washed 3 times with TBST between each incubation. Membranes were incubated with a 1:5000 dilution of rabbit-anti-Klebsiella OmpA antibody (Antibody Research Corporation #111226) for 1 hour at room temperature, followed by incubation in a 1:10,000 dilution of HRP-conjugated goat-antirabbit secondary antibody (Thermo Fisher #65-6120). Blots were treated with Pierce ECL Western
Blotting Substrate (Thermo Fisher #32106) and chemiluminescence was detected using the Azure Biosystems c300 Imaging system. To lyse cells, the pellet was resuspended in 50 mL membrane wash buffer supplemented with 1X
Purification of K. pneumoniae
protease inhibitor (Roche cat no. 04693159001) and 10mg/mL lysozyme and let shake on ice for 30 minutes before sonication at 70% amplitude, 20 seconds on/ 20 seconds off for a total of 8 minutes.
1mM PMSF and 5mM Beta-mercaptoethanol were added to the lysates following sonication. Unlysed cells were removed via centrifugation at 1,500xg for 10 minutes, 4°C. Cleared lysates were spun at 100,000xg, 4°C for 1 hour, washed once with membrane wash buffer supplemented with 1x protease inhibitor and 1mM fresh PMSF, and spun again with the same settings. The pelleted total membrane fraction was resuspended once more in 3mL supplemented membrane wash buffer. To solubilize membranes and isolate protein, the resuspended membranes were mixed with 5% of 3:1 Styrenemaleic acid copolymer (3:1 SMA) in wash buffer and solubilized rolling at room temperature for two hours to allow the formation of membrane nanodiscs 49 . Following incubation, insoluble material was 
Flow cytometry analysis
On days 4 or 6, organoids were rinsed in 1X PBS and enzymatically digested in 125 U/mL collagenase type 1 (Worthington Biochemical) for 1 h at 37°C. Enzyme activity was terminated by addition of buffer containing serum, and the cells were filtered to remove organoid debris using 96 well 
Statistical analysis
Statistical analysis was performed using GraphPad Prism software. Data analysis used an unpaired two-tailed t test or one-way analysis of variance (ANOVA) with Tukey's post hoc test or two-way ANOVA with Sidak's multiple comparison test. Quantitative analyses as scatter or bar graphs are presented as means ± SEM. In all studies, *P < 0.05, **P < 0.01, and ***P < 0.001 unless otherwise stated. Non-significance is denoted by "ns."
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